CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 5.65 USD -1.57% Market Closed
Market Cap: $957.3m

Profitability Summary

CytomX Therapeutics Inc's profitability score is 55/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

55/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

55/100
Profitability
Score
55/100
Profitability
Score

Margins

Earnings Waterfall
CytomX Therapeutics Inc

Margins Comparison
CytomX Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
CytomX Therapeutics Inc
NASDAQ:CTMX
932.6m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
CytomX Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
CytomX Therapeutics Inc
NASDAQ:CTMX
932.6m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
CytomX Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate